Infectious Disease Immunoassays Markets, 2021

News provided by

Nov 15, 2017, 17:00 ET

DUBLIN, November 15, 2017 /PRNewswire/ --

The "World Market for Infectious Disease Immunoassays" report has been added to Research and Markets' offering.

The World Market for Infectious Disease Immunoassays, provides important business planning data for companies in the immunoassay market, investing in the field, or considering expansion.

A key area of immunoassay testing is in detecting infectious diseases. The infectious disease immunoassay market is large because of the many different infectious agents affecting the population. Common infectious disease immunoassays performed in central laboratories are typically categorized into groups such as hepatitis, retroviral testing, sexually transmitted diseases, TORCH, and other infectious diseases. Infectious disease immunoassays are used in point-of-care setting or when rapid testing is needed. Immunoassays are also used to screen blood and blood products in order to prevent transfusion-transmitted infections.

Some infectious disease immunoassays are being replaced with molecular assays. For example, most chlamydia and gonorrhea testing in developed countries is performed with molecular diagnostic assays rather than with immunoassays. A major driving factor in this conversion to molecular testing for chlamydia and gonorrhea was the increased sensitivity of these molecular tests compared to traditional immunoassays, and especially compared to traditional rapid tests such as lateral flow-based assays.

However, many improvements have been made with immunoassays to improve the technical performance of these assays, including better sensitivity. Innovations in immunoassay technology and platforms have been discussed in Chapter 4, and many companies developing these new, innovative platforms are profiled in this report.

Immunoassays for many infectious diseases are a mature market. Tests have been available for many of these agents for years or decades. Growth in this market will primarily be fueled by the identification of new infectious agents for which testing may be needed, and by growth of diagnostic testing in developing countries where infectious diseases are a major problem.

Diseases such as HIV, HBV, and HCV infection are major problems worldwide, and growth of the IVD market in developing countries is fueling growth in the overall infectious disease immunoassay market. In addition, developing countries also need tests for other diseases (such as malaria and others) that are not common in the United States or Europe.

Key Topics Covered:

1: Executive Summary

Overview
Scope And Methodology
Future Prospects In The Infectious Disease Immunoassay Market

2: Introduction

History And Future Of Immunoassays
Point Of View
Elisa
Radioimmunoassays
Overview - Instrument Platforms
Automation
Platform Innovations - Miniaturization, Microfluidics and Multiplexed Assays
Specimen Types
Blood
Urine
Saliva
Rapid And Point-Of-Care Testing
POC Testing in Hospitals
Physician's Office Laboratories and Clinics
Retail Clinics
Other Professional POC Testing
Self-Testing
Immunoassay Market - Market Drivers And Changes
Emerging International Markets
Outlook For Immunoassays

3: Infectious Disease Immunoassays Market Analysis

Infectious Disease
Hepatitis
Retroviral
Sexually Transmitted Diseases
TORCH
Other Infectious Diseases -Immunoassays in Central Laboratories
Rapid and POC Testing
Blood Testing
Lab-Based Infectious Disease Immunoassay Market By Disease
Point Of Care/Rapid Test Immunoassays
Market By Country - Lab-Based
Market by Country Point of Care

4. Company Profiles

Accubiotech Co, Ltd.
Alere Inc
Arkray, Inc
Arlington Scientific, Inc.
Atlas Link Biotech Co., Ltd
Beckman Coulter, Inc
Becton Dickinson (Bd)
Biokit S.A.
Biomerieux Sa
Bio-Rad Laboratories Inc
Bioscan Screening Systems, Inc.
Chembio Diagnostic Systems, Inc.
Diasource Immunoassays Sa
Erba Diagnostics, Inc.
Grifols International S.A.
Hema Diagnostic Systems, Llc
Labsystems Diagnostics Oy
Luminex Corporation
Medix Biochemica
Medmira, Inc
Meridian Bioscience, Inc
Nano-Ditech Corporation
Novatec Immunodiagnostica Gmbh
Oncimmune Holdings Plc.
Operon
Orasure Technologies, Inc.
Quidel Corporation
Response Biomedical Corp
Savyon Diagnostics Ltd.
Sekisui Diagnostics
Siemens Healthineers
Standard Diagnostics, Inc.
Teco Diagnostics
Thermo Fisher Scientific, Inc
Trinity Biotech Plc

For more information about this report visit https://www.researchandmarkets.com/research/tfmk52/world_market_for

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets